イベント

すべて表示
    AACR 2022

    AACR 2022

    March 24, 2022
    〜でシェア:


    The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.

    Poster session:

    Humanized models and efficacy studies

    Evaluating In Vivo Efficacy of Anti-VSIG4 Antibodies in Humanized B-hVSIG4 Mice

    Session Category: Tumor Biology

    Poster Number: 1642

    Generation and Validation of Humanized GARP Mice for Testing Novel Anti-Human GARP Antibodies

    Session Category: Tumor Biology

    Poster Number: 1644

    Advancing the Development of CD16A-Based Bispecific Antibodies in Humanized CD16A Mouse Models

    Session Category: Tumor Biology

    Poster Number: 1645

    Humanized TROP2 Mice Provide a Preclinical Tool for the Evaluation of Therapeutic Drugs Targeting TROP2

    Session Category: Tumor Biology

    Poster Number: 1646

    Evaluation of Therapeutic Drug Candidates Using a Novel Humanized B-hCSF1/hCSF1R

    Session Category: Tumor Biology

    Poster Number: 1648

    Humanized PVRIG Mice: A Novel Tool for Evaluating Anti-PVRIG Immunotherapies

    Session Category: Tumor Biology

    Poster Number: 1649

    Generation of a Novel Humanized TLR8 Mouse Model for the Evaluation of Human TLR8 Agonists and Antibody-Conjugated TLR8 Agonists

    Session Category: Tumor Biology

    Poster Number: 1651

    A Humanized Mouse Model of the Promising Immune Checkpoint Molecule B7-H4

    Session Category: Tumor Biology

    Poster Number: 1652

    1C3, a Novel Non-blocking Anti-human TNFR2 Antibody Generated From RenMice, Exhibits Promising Anti-tumor Activity and Safety in Syngeneic Tumor Models in Humanized TNFR2 Mice

    Session Category: Immunology

    Poster Number: 2907

    Evaluating Delivery of TFR1-targeting Therapies to the CNS in a Novel Humanized TFR1 Mouse Model

    Session Category: Experimental and Molecular Therapeutics

    Poster Number: 377

    Preclinical bispecific antibody/ADC candidates 

    Generation of TCR-like fully human antibodies against HLA-antigen-peptide complexes using HLA transgenic RenMice

    Session Category:  Therapeutic Antibodies

    Poster Number: 2885

    YH012, a Novel Bispecific Anti-HER2 and TROP2 Antibody-Drug Conjugate, Exhibits Potent Antitumor Efficacy

    Session Category: Immunology

    Poster Number: 4256

    E-Poster

    YH008, a PD-1-CD40 Bispecific Antibody, Inhibits Tumor Growth In Vivo Through PD-1-Dependent Activation of CD40 Signaling

    Session Category: Immunology

    Poster Number: 5615

     Immuno-oncology and Inflammatory/Metabolic Disease Modeling

    Developing a Translational Tool for GLP-1-Based Therapeutic Agonists in Humanized GLP1R Mice

    Session Category: Prevention/Early Detection/Interception

    Poster Number: 3

    B-hIL12A/hIL12B/hIL12RB1/hIL12RB2: A Novel Animal Model for Generation of IL12 Therapies

    Session Category: Tumor Biology

    Poster Number: 1643

    Identifying New Therapeutic Antibodies Using Knockout Mice Expressing Human Immunoglobulin Variable Domain Genes

    Session Category: Experimental and Molecular Therapeutics

    Poster Number: 1891

    Evaluating In Vivo Efficacy of Peptide Vaccines in Humanized B-HLA-A2.1 Mice

    Session Category: Clinical Research Excluding Trials

    Poster Number: 1992

    Functional Analysis of Anti-TSLP Antibodies Using Humanized B-hTSLP/hTSLPR Mice

    Session Category: Immunology

    Poster Number: 2089